oasis-1 oral semaglutide 50 mg obesity nejm 2023 taken once per day in adults with overweight or (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial Most viewed this week from – In the OASIS 4 phase

Resources We Trust Mayo Clinic: Alcohol Use Disorder: Diagnosis & Treatment Cleveland Clinic: GLP-1 Agonists National Institute on Alcohol Abuse and Alcoholism: Understanding Alcohol Use Disorder American Psychiatric Association: Alcohol Use Disorder MedlinePlus: Alcohol Use Disorder (AUD) Brunchmann A et al

Dosing schedules compared Both drugs use once-weekly subcutaneous injection with gradual dose titration

Recommendation #3

The scale doesnt move the way it does for almost everyone else on either drug

Minimizes the appearance of skin imperfections and imparts a beautiful radiance

Your body is trying to process more food than it is comfortable holding at once